Skip to main content
. 2014 Jan 30;16(5):748–753. doi: 10.1093/neuonc/not320

Table 1.

Characteristics of enrolled patients

Patient Age at Dx (years) Sex Dx Rx Prestudy Time From Dx to Study (months) M-stage Prestudy Time From Last Rx to Study (months) Relapses (n) TMZ Cycles (n)
1 12 M MB S,RT,CT,PBSCR 34 M3 9 4 10
2 7 M MB S,CT,RT 18 M3 3 3 6
3 10 M MB S,CT,RT,PBSCR 42 M3 2 4 17
4 18 M MB S,CT,RT,PBSCR 14 M3 3 2 2
5 10 M MB S,CT,RT,PBSCR 19 M3 7 2 6
6 5 F MB S,CT,RT,PBSCR 20 M3 6 2 2
7 10 M MB S,CT,RT,PBSCR 19 M3 9 2 6
8 21 M MB S,CT,RT,PBSCR 33 M3 21 2 10
9 4 M MB S,CT,RT,PBSCR 27 M3 15 2 2
10 10 M MB S,CT,RT,PBSCR 35 M3 22 2 15
11 18 F PNET S,CT,RT 60 M2 55 2 10
12 13 M MB S,RT,CT 43 M3 30 1 11
13 7 M MB S,CT,RT 17 M3 5 2 5
14 4 F MB S,CT,RT 10 M2 2 1 2
15 20 F MB S,RT,CT 26 M3 18 2 4
16 7 M MB S,RT,CT 12 M3 2 2 11
17 6 M MB S,RT,CT 45 M3 33 1 22
18 6 M PNET S,RT,CT,PBSCR 25 M3 2 3 2
19 10 M PNET S,CT,RT 18 M2 5 2 2
20 13 M MB S,RT,CT 36 M3 17 3 6
21 2 M MB S,CT,PBSCR 5 M2 2 2 4
22 16 M MB S,RT,CT 6 M3 1 1 4
23 11 M MB S,RT,CT,PBSCR 48 M3 6 2 3
24 11 M MB S,RT,CT 15 M2 8 2 10
25 2 M MB S,CT,PBSCR 10 M3 4 2 9
26 3 F MB S,CT 6 M3 3 2 2
27 18 M MB S,RT,CT,PBSCR 10 M2 2 2 4
28 3 M MB S,CT 5 M3 2 2 4
29 6 F MB S,RT,CT 12 M2 4 2 12
30 12 F MB S,RT,CT 12 M3 4 2 8
31 17 M MB S,RT,CT 15 M3 8 2 9
32 9 M MB S,RT,CT,PBSCR 27 M3 8 2 6
33 15 F MB S,RT,CT,PBSCR 29 M2 4 2 2
34 15 M MB S,RT,CT 6 M3 2 2 7
35 18 F MB S,RT,CT,PBSCR 17 M3 17 3 13
36 9 M MB S,RT,CT,PBSCR 16 M3 9 2 7
37 17 M MB S,RT,CT 9 M3 7 2 4
38 8 M MB S,RT,CT 20 M3 24 2 11
39 9 M MB S,RT,CT 11 M2 14 2 6
40 9 M MB S,RT,CT 13 M3 2 1 2

Abbreviations: Dx, diagnosis; PBSCR, peripheral blood stem cell rescue; RT, craniospinal irradiation plus boost to the posterior fossa; Rx, treatment; S, surgery; CT, chemotherapy.